Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Vitamin E in T2DM and NAFLD
NCT01720719Phase 4Unknown
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in non-alcoholic fatty liver disease (NAFLD), dyslipidemia. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)dyslipidemia
Beyond the preview
Go deeper on NCT01720719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720719.